Melphalan-prednisone versus dexamethasone-based regimens in elderly patients with multiple myeloma ineligible for high-dose therapy

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)488-490
Number of pages3
JournalAmerican Journal of Oncology Review
Volume5
Issue number8
StatePublished - Aug 2006

Fingerprint

Melphalan
Prednisone
Multiple Myeloma
Dexamethasone
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Oncology(nursing)

Cite this

@article{4894aec5aece4716852c5f80428db211,
title = "Melphalan-prednisone versus dexamethasone-based regimens in elderly patients with multiple myeloma ineligible for high-dose therapy",
author = "Angela Dispenzieri",
year = "2006",
month = "8",
language = "English (US)",
volume = "5",
pages = "488--490",
journal = "American Journal of Hematology/ Oncology",
issn = "1542-9520",
publisher = "TyWin Communications",
number = "8",

}

TY - JOUR

T1 - Melphalan-prednisone versus dexamethasone-based regimens in elderly patients with multiple myeloma ineligible for high-dose therapy

AU - Dispenzieri, Angela

PY - 2006/8

Y1 - 2006/8

UR - http://www.scopus.com/inward/record.url?scp=33747893090&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747893090&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33747893090

VL - 5

SP - 488

EP - 490

JO - American Journal of Hematology/ Oncology

JF - American Journal of Hematology/ Oncology

SN - 1542-9520

IS - 8

ER -